Zai Lab Ltd. ADR (ZLAB) Social Stream
ZAI LAB LTD (ZLAB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ZAI LAB LTD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-22 | 5 | $225 | $189 | $203.325 | $30.21 | 573.04% |
| 2021-11-10 | 6 | $225 | $189 | $201.825 | $30.21 | 568.07% |
| 2021-11-11 | 6 | $225 | $189 | $204.86 | $30.21 | 578.12% |
| 2021-12-15 | 6 | $225 | $136 | $194.26 | $30.21 | 543.03% |
| 2021-12-22 | 6 | $217 | $125 | $174.26 | $30.21 | 476.83% |
| 2022-01-06 | 6 | $217 | $125 | $174.08 | $30.21 | 476.23% |
| 2022-01-21 | 7 | $217 | $64 | $155.733 | $30.21 | 415.5% |
| 2022-03-30 | 7 | $217 | $64 | $119.833 | $30.21 | 296.67% |
| 2022-04-04 | 7 | $217 | $64 | $115.833 | $30.21 | 283.43% |
| 2022-04-21 | 7 | $217 | $64 | $115.666 | $30.21 | 282.87% |
| 2022-05-11 | 7 | $217 | $64 | $108.75 | $30.21 | 259.98% |
| 2022-07-22 | 7 | $193 | $64 | $105.25 | $30.21 | 248.39% |
| 2022-08-05 | 7 | $193 | $64 | $104.083 | $30.21 | 244.53% |
| 2022-08-09 | 7 | $199 | $64 | $105.083 | $30.21 | 247.84% |
| 2022-08-13 | 7 | $199 | $64 | $103.383 | $30.21 | 242.21% |
| 2022-09-17 | 7 | $199 | $64 | $101.383 | $30.21 | 235.59% |
| 2022-10-31 | 6 | $199 | $64 | $98.883 | $30.21 | 227.32% |
| 2022-11-11 | 6 | $127 | $64 | $86.883 | $30.21 | 187.6% |
| 2022-11-18 | 4 | $127 | $65 | $88.06 | $30.21 | 191.49% |
| 2023-03-01 | 5 | $127 | $65 | $88.06 | $30.21 | 191.49% |
| 2023-03-03 | 5 | $127 | $65 | $87.6 | $30.21 | 189.97% |
The Trend in the Analyst Price Target
Over the past 29 months, ZLAB's average price target has gone down $12.02.
ZLAB reports an average of 153.03% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-04 | 7 | 217 | 64 | 115.833 | 49.68 | 133.16% |
| 2022-08-13 | 7 | 199 | 64 | 103.383 | 44.17 | 134.06% |
| 2022-10-31 | 6 | 199 | 64 | 98.883 | 22.28 | 343.82% |
| 2023-01-26 | 5 | 127 | 65 | 88.060 | 44.47 | 98.02% |
| 2023-03-01 | 5 | 127 | 65 | 88.060 | 40.38 | 118.08% |
ZLAB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 32 months, ZLAB's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ZLAB as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, ZAI LAB LTD's upside potential (average analyst target price relative to current price) is higher than 2178.5% of them.
- To contextualize these metrics, consider that out of stocks in the large market cap category, ZAI LAB LTD's number of analysts covering the stock is greater than 228.02% of them.
- ZAI LAB LTD's average analyst price target is higher than 2186.46% of Pharmaceutical Products stocks.
- ZLAB has a lower variance in analysts' estimates than -1786.16% of stocks in the large market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ZAI LAB LTD are RDY, BGNE, and GSK.
View All Top Stocks by Price Target
Is ZLAB a Buy, Hold or Sell? See the POWR Ratings now!